TrimRx's Blog

Tirzepatide triggers cellular autophagy and reduces inflammatory markers linked to aging. Research shows metabolic improvements extend beyond weight loss

Tirzepatide impacts brain health through GLP-1 and GIP receptor activation, improving insulin sensitivity and reducing neuroinflammation in key cognitive

Tirzepatide delivers 20–25% body weight reduction at 1 year in clinical trials. Here’s the month-by-month breakdown, plateau patterns, and what determines

Tirzepatide 1 year results show 15-21% body weight loss in clinical trials, with sustained metabolic improvements and manageable side effects through

Tirzepatide delivers 15-20% body weight reduction at 6 months when combined with structured support — here’s what determines your specific outcome.

Tirzepatide delivers 21-26% body weight reduction at 104 weeks in SURMOUNT trials, with sustained A1C improvements and cardiovascular benefits across

Tirzepatide shows sustained weight loss in long-term trials, with most patients maintaining 15-20% reduction after five years when adherence remains

Tirzepatide reduces body fat but may impair explosive power and recovery in athletes through glycogen depletion and reduced caloric intake mechanisms.

Tirzepatide affects CrossFit performance through altered glycogen storage and recovery timing. Here’s what athletes need to know before combining them.